It indeed might be all the money that LPath will need forever.
However, many biotechs will raise more money than they really need anyway, just in case.
Must have added too soon again. They might bring this down below 11 before options expiration again.
I'm tempted to add especially since it seems like an agreement have been reached over several bottles of Stolichnaya.
That's what I've been saying; IMGN at the current pps would fall under Buffett value stock. Beaten down price with promising revenue in the near term. Just one more good partnered drug and we'll make money on this dog. A pleasant surprise with one of their own drug, and we'll make even more. Would be nice if Roche drops pertuzumab, or docs just decide to go with Kadcyla, instead of fooling around with using pertuzumab
Yeah, not much of a confidence booster from someone who earns at least 375k a year. If officers are really that confident of Isonep success, you would think that they would be risking as much as the INO CEO's $2.2M buy. Still better than none.
What I mean is that it would fall into stocks that Buffett would consider a value investment, because pps is beaten down at the moment , yet it has steady revenue, the certainty of increasing revenu, and the possibility of so much more, coming from a very promising platform technology.
It will just be a question of when will it be too late to be on board on this one. 2015 will probably be not that late yet.
I wonder because in 2016, Kadcyla should bring enough revenue for annual expenses. Add to that the other partnered compounds, and one lucky IMGN wholly owned ADC and IMGN should leave this solar system.
Pps went down, but your stock buy gives our sagging confidence a boost. Please encourage the other highly paid LPath officers to follow your lead to show us a clear and bright sign that all is well with our Mabs and that we are all in this little boat together.
You're late! I got more today at 2.76 and 2.80! 2.76 only got partially filled though.
Good job, Scott! Now, get your boys to follow your lead.
Just talking about the need for some confidence-boosting insider buys, then the following week Scott buys. Maybe an honest attempt by Scott to boost pps, but I guess buying 10,000 shares was not much of a confidence boost. Instead, it made many investors doubt as to how good the trial results are going with the CEO not willing to put 100,000$ on the table. INO CEO bought more than $2M worth of 250,000 shares. Now, that is really saying that their technology will definitely work, even though it may not in the end. Scott only owns 106k shares with the last filing and brought attention to the 6000 shares he sold in Feb. Let's see if other insiders will show more conviction in LPath.
Today will be my last buy. Don't want to risk anything anymore. This is just badly played and manipulated. Lpath should just go private until Isonep results are out.
But his asking price was 3.05, and that is what brought the pps down. I outbid him since I got mine at 3.15. To further outdo him, I'm thinking of adding more at 3.20.
Is there any way to stop trading for 6 months?
Why is Russia punishing it's own people? Putin's gonna starve the Russians like Stalin did. Will Snowden still be a happy Russian?
Are you not feeling insecure now that it seems you're not the only knowledgeable pumper on this board? LOL!
Anyway, welcome to the other well-informed posters.
I'm buying if that insider selling pulls this back down below 9. I actually added too soon at 9.30.
I was thinking that he might be dying and needs to put his finances in order. If he is staying, he probably has more than 100,000 unvested options still remaining.